{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP03686",
    "Peptide Name": "IR2 (Ile-rich; Arg-rich; synthetic AMPs, XXA, 1S=S, UCSS1; BBMm)",
    "Source": "de novo designed, man-made sequences",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "IRIRCRRRFCRIRI",
    "Sequence Length": 14,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 8,
    "Boman Index": 5.65,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "50%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals this sequence is most similar (50%) toProtegrin 2R: 50%; I: 29%; C: 14%.  GRAVY: -0.41; M Wt: 1917.438; Mol formula:  C81H149N35O15S2; molar extinction coeff: 125.Activity: active against Gram- E. coli ATCC 25922 (MIC 1 uM), S. Pullorum C79-13 (MIC 1 uM), S. enterica serovar Typhimurium C77-31 (MIC 4 uM), B. yocyaneum ATCC 27853 (MIC 4 uM), Gram+ S. aeurus ATCC 29213 (MIC 4 uM), S. epidermidis ATCC 12228 (MIC 4 uM),  S. faecalis ATCC 29212 (MIC 4 uM), and B. subtilis CMCC 63501 (MIC 2 uM).Antimicrobial robustness:  NaCl-insensitive:E. coli (150 mM salt); KCl-sensitized:E. coli (4.5 mM salt), NH4Cl-sensitized:E. coli (6 uM salt), MgCl2-insensitive:E. coli (1 mM salt), CaCl2-insensitive:E. coli (2.5 mM salt); ZnCl2-insensitive:E. coli (8 uM salt), FeCl3-insensitive:E. coli (4 uM salt); NaCl-insensitive:S. aureus (150 mM salt); KCl-insensitive:S. aureus (4.5 mM salt), NH4Cl-sensitized:S. aureus (6 uM salt), MgCl2-insensitive:S. aureus (1 mM salt), CaCl2-insensitive:S. aureus (2.5 mM salt); ZnCl2-insensitive:S. aureus (8 uM salt), FeCl3-insensitive:S. aureus (4 uM salt).Toxicity: 128 uM peptide caused 10% hemolysis, very low hemo.lytic Provided by Arjun Nair.",
    "Author": "Dong N, Zhu X, Chou S, Shan A, Li W, Jiang J.2014",
    "Reference": "Biomaterials. 2014 Sep;35(27):8028-39. doi: 10.1016/j.biomaterials.2014.06.005.Pub-Med.",
    "Title": "Antimicrobial potency and selectivity of simplified symmetric-end peptides."
  },
  "3D Structure": []
}